Sub-microscopic Plasmodium falciparum parasitaemia, dihydropteroate synthase (dhps) resistance mutations to sulfadoxine–pyrimethamine, transmission intensity and risk of malaria infection in pregnancy in Mount Cameroon Region
-
Published:2023-03-02
Issue:1
Volume:22
Page:
-
ISSN:1475-2875
-
Container-title:Malaria Journal
-
language:en
-
Short-container-title:Malar J
Author:
Mbacham Harry F.,Mosume Diange M,Apinjoh Tobias O.,Ntui Vincent N.,Moyeh Marcel N.,Kalaji Laken N.,Wepnje Godlove B.,Ghogomu Stephen M,Dionne Jodie A,Tita Alan T.N.,Achidi Eric A.,Anchang-Kimbi Judith K.
Abstract
AbstractBackgroundPlasmodium falciparumresistance to intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) continues to spread throughout sub-Saharan Africa. This study assessed the occurrence of microscopic and sub-microscopicP. falciparumparasitaemia, dihydropteroate synthase mutations associated with resistance to SP and maternal anaemia in the Mount Cameroon area.MethodsConsenting pregnant women living in semi-rural and semi-urban/urbanized settings were enrolled in this cross-sectional study. Socio-demographic, antenatal and clinical data were documented. Microscopic and sub-microscopic parasitaemia were diagnosed using peripheral blood microscopy and nested polymerase chain reaction (PCR) respectively. Thedhpsmutations were genotyped by restriction fragment length polymorphism analysis. The presence of A437G, K540E, and A581G was considered a marker for high-level resistance. Haemoglobin levels and anaemia status were determined.ResultsAmong the women, the prevalence of microscopic and sub-microscopicP. falciparuminfection were 7.7% (67/874) and 18.6% (93/500) respectively. Predictors of microscopic infection were younger age (< 21 years) (AOR = 2.89; 95% CI 1.29–6.46) and semi-rural settings (AOR = 2.27; 95% CI 1.31–3.96). Determinants of sub-microscopic infection were the rainy season (AOR, 3.01; 95% CI 1.77–5.13), primigravidity (AOR = 0.45; 95% CI 0.21–0.94) and regular ITN usage (AOR = 0.49; 95% CI 0.27–0.90). Of the145P. falciparumisolates genotyped, 66.9% (97) carried mutations associated with resistance to SP; 33.8% (49), 0%, 52.4% (76) and 19.3% (28) for A437G, K540E, A581G and A437G + A581G respectively. The A581G mutation was associated with ≥ 3 SP doses evident only among sub-microscopic parasitaemia (P = 0.027) and multigravidae (P = 0.009). Women with microscopic infection were more likely from semi-rural settings (AOR = 7.09; 95% CI 2.59–19.42), to report history of fever (AOR = 2.6; 95% CI 1.07–6.31), to harbour parasites with double resistant mutations (AOR = 6.65; 95% CI 1.85–23.96) and were less likely to have received 2 SP doses (AOR = 0.29; 95% CI 1.07–6.31). Microscopic infection decreased Hb levels more than sub-microscopic infection.ConclusionThe occurrence of sub-microscopicP. falciparumparasites resistant to SP and intense malaria transmission poses persistent risk of malaria infection during pregnancy in the area. ITN usage and monitoring spread of resistance are critical.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference80 articles.
1. Gore-Langton GR, Cano J, Simpson H, Tatem A, Tejedir-Garavito N, Wigley A, et al. Global estimates of pregnancies at risk of Plasmodium falciparum and Plasmodium vivax infection in 2020 and changes in risk patterns since 2000. PLoS Glob Public Health. 2022;2:e0001061.
2. WHO. Implementing malaria in pregnancy programs in the context of World Health Organization recommendations on antenatal care for a positive pregnancy experience. Geneva: World Health Organization; 2018.
3. WHO. Evidence review group on intermittent preventive treatment (IPT) of malaria in pregnancy. Geneva: World Health Organization; 2013.
4. WHO. Guidelines for malaria. Geneva: World Health Organization; 2022.
5. WHO. World malaria report 2019. Geneva: World Health Organization; 2019.